相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections
Pranita D. Tamma et al.
CLINICAL INFECTIOUS DISEASES (2022)
Colistin heteroresistance in carbapenem-resistantAcinetobacter baumanniiclinical isolates from a Thai university hospital
Khin Thet Thet et al.
WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY (2020)
Clinical Outcomes Of Colistin In Combination With Either 6-G Sulbactam Or Carbapenems For The Treatment Of Extensively Drug-Resistant Acinetobacter Baumannii Pneumonia With High MIC To Sulbactam, A Prospective Cohort Study
Chutchawan Ungthammakhun et al.
INFECTION AND DRUG RESISTANCE (2019)
Antimicrobial Susceptibility among Colistin, Sulbactam, and Fosfomycin and a Synergism Study of Colistin in Combination with Sulbactam or Fosfomycin against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii
Sombat Leelasupasri et al.
JOURNAL OF PATHOGENS (2018)
Dosing Guidance for Intravenous Colistin in Critically Ill Patients
Roger L. Nation et al.
CLINICAL INFECTIOUS DISEASES (2017)
Population Pharmacokinetics and Pharmacodynamics Modeling To Optimize Dosage Regimens of Sulbactam in Critically Ill Patients with Severe Sepsis Caused by Acinetobacter baumannii
Sutep Jaruratanasirikul et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
Andre C. Kalil et al.
CLINICAL INFECTIOUS DISEASES (2016)
Molecular Mechanisms of Sulbactam Antibacterial Activity and Resistance Determinants in Acinetobacter baumannii
William F. Penwell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Task force on management and prevention of Acinetobacter baumannii infections in the ICU
Jose Garnacho-Montero et al.
INTENSIVE CARE MEDICINE (2015)
Colistin alone or combined with sulbactam or carbapenem against A. baumannii in ventilator-associated pneumonia
Gul Ruhsar Yilmaz et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2015)
Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections
A. Batirel et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2014)
Comparison of colistin and colistin/sulbactam for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia
G. Kalin et al.
INFECTION (2014)
Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia
Thana Khawcharoenporn et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii
Wentao Ni et al.
JOURNAL OF ANTIBIOTICS (2013)
White Paper: Recommendations on the Conduct of Superiority and Organism-Specific Clinical Trials of Antibacterial Agents for the Treatment of Infections Caused by Drug-Resistant Bacterial Pathogens
Brad Spellberg et al.
CLINICAL INFECTIOUS DISEASES (2012)
Risk Factors for Mortality in Patients with Carbapenem-Resistant Acinetobacter baumannii Bacteremia: Impact of Appropriate Antimicrobial Therapy
Youn Jeong Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2012)
Treatment of Acinetobacter infections
Argyris Michalopoulos et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Antimicrobial Treatment and Clinical Outcomes of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia
Jeannie D. Chan et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2010)
Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme
Wing Yau et al.
JOURNAL OF INFECTION (2009)
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007
Alicia I. Hidron et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Potential for underdosing and emergence of resistance in Acinetobacter baumannii during treatment with colistin
Miruna D. David et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
M. S. Oliveira et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia
Alex P. Betrosian et al.
JOURNAL OF INFECTION (2008)
Current control and treatment of multidrug-resistant Acinetobacter baumannii infections
Drosos E. Karageorgopoulos et al.
LANCET INFECTIOUS DISEASES (2008)
Global challenge of multidrug-resistant Acinetobacter baumannii
Federico Perez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand
Pornpan Koomanachai et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2007)
Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study
H. Kallel et al.
INTENSIVE CARE MEDICINE (2007)
Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia
Ki Tae Kwon et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
High-dose ampicillin-sulbactam as an alternative treatment of late-onset VAP from multidrug-resistant Acinetobacter baumannii
Alex P. Betrosian et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2007)
Multildrug-resistant Acinetobacter infection mortality rate and length of hospitalization
Rebecca H. Sunenshine et al.
EMERGING INFECTIOUS DISEASES (2007)
Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU
Hatem Kallel et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
The epidemiology and control of Acinetobacter baumannii in health care facilities
PE Fournier et al.
CLINICAL INFECTIOUS DISEASES (2006)
Combination therapy with intravenous colistin for management of infections due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis
SK Kasiakou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii
C Urban et al.
CLINICAL INFECTIOUS DISEASES (2003)
分享论文
